home / compare / distrolens vs cognism
comparison · cognism alternative for pharma distribution

Distrolens vs Cognism

Factual side-by-side: what each tool does, where each is strong, and where each is thin. Cognism is positioned as gdpr-compliant b2b contact data and sales intelligence. Distrolens is positioned as named distributor intelligence for 21 emerging markets (Nigeria, Saudi Arabia, UAE, Kenya, and 17 more), sourced from regulator registries.

what cognism does

Cognism

Cognism positions as GDPR-/CCPA-compliant B2B contact data for European markets. Diamond tier includes phone-verified mobile contacts. Strong in EMEA tech-vertical prospecting; recently expanded to North America.

serves best
  • EMEA-focused B2B sales teams that need GDPR-compliant contact data
  • Phone-heavy outbound motions (SDR phone outreach)
  • Tech-vertical and SaaS prospecting in Europe
what distrolens does

Distrolens

Pharma distribution intelligence: named distributors across 21 emerging markets, sourced from regulator registries (NAFDAC, SFDA, MOHAP, SAHPRA, EudraGMDP, TED). Verified contact emails, supply-chain edges, sanctions screening (14-day half-life), and live Chao1 coverage published per country including where we are weak.

serves best
  • Pharma + medtech brand owners entering emerging markets
  • Market-entry assessments needing named distributor candidates
  • Sales teams needing verified-email outreach pipeline into EM pharma
  • Due-diligence with sanctions screening + regulator-license context

Side-by-side

4 dimensions. Claims are factual and citable — sourced from Cognism’s own public materials and Distrolens production data. No marketing puffery either way.

dimension
Vertical specialisation
Cognism

Cross-industry B2B — tech, SaaS, financial services, pharma all in one schema. Pharma-specific signals (regulator licenses, drug registrations) absent

distrolens

Pharma + medtech only. Every record carries regulator-license metadata; you can filter by 'has active NAFDAC license, expiring within 90 days'

dimension
Geographic depth
Cognism

EMEA strong (UK, DACH, Nordics), expanding US — emerging markets (Sub-Saharan Africa, GCC pharma, South Asia) are thin

distrolens

21 emerging markets are the primary scope, 8 sales-ready

dimension
Source provenance
Cognism

Contact-data aggregation methodology summarised but not per-record source-traced

distrolens

Every company shows which regulators or open-data sources confirm it, with last-verified timestamp. Sales call narrative material

dimension
Compliance overlap
Cognism

GDPR/CCPA compliance posture is the primary differentiator vs ZoomInfo

distrolens

We screen against OpenSanctions live (14-day half-life) and surface sanctions flags per company. Cognism doesn't offer integrated sanctions screening

cognism pricing

Tiered annual subscriptions — typical £15K-30K/yr for Diamond plan including phone-verified contacts

Contract: Annual contracts, seat-based.
Source: Public Cognism positioning + analyst comparisons (G2, TrustRadius), exact figures under NDA

distrolens pricing

$500/country/month List · $1,200/country/month Intel · bundle discounts −15% / −25% / −30% at 3 / 6 / 10+ countries.

Contract: month-to-month, no minimum, cancel any month.
20-minute discovery call required before CSV + REST API access.

When to choose which.

choose Cognism

You're an EMEA-focused B2B SaaS team needing GDPR-compliant outbound contacts in tech-vertical accounts.

choose distrolens

You're targeting pharma distributors in emerging markets and need regulator-license + sanctions-screen context that generic B2B contact tools don't provide.

related — services
uaesaudi arabiakenyanigeria
related — comparisons
→ distrolens vs IQVIA→ distrolens vs ZoomInfo